Discover our value-focused philosophy and unique venture ecosystem.
See how we're scaling the future of CPG brands.
The LvlUp Ventures First Check Fund. 1,000 investments in 2026.
Learn how we're backing the next generation of e-commerce ecosystem technology.
See how we're powering non-dilutive growth for pre-seed to growth-stage startups.
Enabling non-dilutive growth for CPG startups.
Discover LvlUp's unique venture debt / non-dilutive financing fund for B2B startups.
Supporting brick-and-mortar and services businesses with non-dilutive growth.
Supporting brick-and-mortar and service businesses with equity capital and financing.
Stay in the know about our upcoming events.
Learn more about our global network of VCs-in-Residence.
Learn more and join one of the largest alliances of enterprises, NGO's and leaders.
Bringing LvlUp's capital, network, and operating infrastructure to the region.
Meet our core, associate, and extended team powering the ecosystem.
Get to know our family of founders and companies.
Read articles from the LvlUp team, our VCs in residence, and guest contributors.
See how founders accelerated growth and gained investor access with LvlUp Ventures.
Learn more about our process and unique offerings for LPs.
LigronBio is a biotechnology company advancing novel molecular glue therapeutics to enable targeted protein degradation and drug the undruggable. The company integrates computational chemistry, machine learning, and AI with experimental data—anchored by its TriMatrix Analyzer platform—to accelerate discovery and candidate design. LigronBio expands the E3 ligase toolkit and partners from early research through clinical development to translate these innovations across oncology, neurology, and other disease areas.
